Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2010

01-10-2010 | Case Report

Rapidly progressive cryoglobulinemic glomerulonephritis

Authors: Nobuo Tsuboi, Mayuri Ichinose, Tetsuya Kawamura, Kensuke Joh, Yasunori Utsunomiya, Tatsuo Hosoya

Published in: Clinical and Experimental Nephrology | Issue 5/2010

Login to get access

Abstract

The clinical course of cryoglobulinemic glomerulonephritis (CGGN) is usually slowly progressive, and only a minority of these patients progress to end-stage renal failure. This report describes an atypical case of a patient with CGGN who demonstrated a rapidly progressive and irreversible renal deterioration. After presenting with symptoms of an upper respiratory infection, the patient exhibited oliguric acute renal failure, which was followed by systemic efflorescence accompanied by a fever. The laboratory analyses of his serum revealed the patient to be cryoglobulin-positive with markedly decreased serum C4 levels and an increased anti-streptolysin O titer. A serological test for the hepatitis C virus was negative. A renal biopsy showed that the patient had diffuse endocapillary and extracapillary proliferation together with marked endoluminal thrombi and subendothelial deposits in glomeruli. An electron microscopic examination demonstrated the presence of electron-dense subendothelial, subepithelial and huge intraluminal deposits with a specific annular and cylindrical structure. These features were consistent with active and severe CGGN. Despite aggressive treatment with corticosteroid pulses and a plasma exchange, a second renal biopsy demonstrated further advanced renal injury and revealed no signs of recovery.
Literature
1.
go back to reference D’Amico G, Colasanti G, Ferrario F, Sinico RA. Renal involvement in essential mixed cryoglobulinemia. Kidney Int. 1989;35:1004–14.CrossRefPubMed D’Amico G, Colasanti G, Ferrario F, Sinico RA. Renal involvement in essential mixed cryoglobulinemia. Kidney Int. 1989;35:1004–14.CrossRefPubMed
2.
go back to reference D’Amico G. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int. 1998;54:650–71.CrossRefPubMed D’Amico G. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int. 1998;54:650–71.CrossRefPubMed
3.
go back to reference Rodriguez-Iturbe B, Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int. 2007;71:1094–104.CrossRefPubMed Rodriguez-Iturbe B, Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int. 2007;71:1094–104.CrossRefPubMed
4.
go back to reference McIntosh RM. Cryoproteins in poststreptococcal glomerulonephritis. Ann Intern Med. 1970;73:857.PubMed McIntosh RM. Cryoproteins in poststreptococcal glomerulonephritis. Ann Intern Med. 1970;73:857.PubMed
5.
go back to reference Garin EH, Fennell RS, Shulman ST, Iravani A, Richard GA. Clinical significance of the presence of cryoglobulins in patients with glomerulopathies not associated with systemic disease. Clin Nephrol. 1980;13:5–11.PubMed Garin EH, Fennell RS, Shulman ST, Iravani A, Richard GA. Clinical significance of the presence of cryoglobulins in patients with glomerulopathies not associated with systemic disease. Clin Nephrol. 1980;13:5–11.PubMed
Metadata
Title
Rapidly progressive cryoglobulinemic glomerulonephritis
Authors
Nobuo Tsuboi
Mayuri Ichinose
Tetsuya Kawamura
Kensuke Joh
Yasunori Utsunomiya
Tatsuo Hosoya
Publication date
01-10-2010
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 5/2010
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-010-0301-4

Other articles of this Issue 5/2010

Clinical and Experimental Nephrology 5/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.